ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 730269 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 730269; 2) Community: the network communities that were significantly associated with the response to NSC 730269; 3) Molecule: the relationships between components within communities and NSC 730269; 4) MDR: the compounds that were significantly associated with the NSC 730269.

NSC Compound Enrichment Correlation
NSC 753585 N1-[6-(trifluoromethyl)-1,3-benzothiazol-2-yl]-2-2-methoxy-5-[(E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propenyl]phenoxyacetamide 0.0152619242759636 0.18295094
NSC 677249 Null 0.0171381695159491 0.1097179
NSC 716522 Null 0.0171381695159491 -0.11503081
NSC 278619 L-Arabinose, 2-amino-4-[(2-amino-1-oxopropyl)amino]-2,4-dideoxy-, monohydrochloride 0.0179905510964914 0.10847005
NSC 610457 Camptothecin Derivative 0.0179905510964914 0.1620081
NSC 622070 Null 0.0179905510964914 -0.22641218
NSC 645069 Null 0.0179905510964914 0.16350875
NSC 657676 Null 0.0179905510964914 0.23442035
NSC 683692 .alpha.-D-Glucopyranoside, phenylmethyl 2-acetylamino-2-deoxy- 3-O-[[2-[[2-[1-(aminocarbonyl)-4-[[5-[(1-nitro- 9-acridinyl)amino]pentyl]amino]-4-oxobutyl]amino]- 1-methyl-2-oxoethyl]amino]-1-methyl-2 0.0179905510964914 0.10270762
NSC 690635 Null 0.0179905510964914 0.042227768
Total:33  Current:10    [First] [Prev] [Next] [Last]